Yeshiva World News · Nov 3, 2026
Yeshiva World News — photo status
A New Jersey drug maker is recalling 3,744 bottles of a combination blood pressure medication after the tablets failed an FDA dissolution test. The Class II recall covers certain lots of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets expiring May 31, 2027; the FDA says the risk of serious harm is remote.
More from Yeshiva World News
- Yeshiva World NewsNov 4, 2026 · DeSantis: This midterm was a rebuke of the president and the
- Yeshiva World NewsNov 4, 2026 · DeSantis: If we can't win in places like Texas or Kansas or
- Yeshiva World NewsNov 4, 2026 · Mayor Zohran Mamdani has directed NYPD and City Hall officia
- Yeshiva World NewsNov 4, 2026 · IDF Chief of Staff Lt. Gen. Eyal Zamir made an unprecedented
- Yeshiva World NewsNov 4, 2026 · Iran says the Strait of Hormuz will reopen only after Washin
- Yeshiva World NewsNov 4, 2026 · President Trump criticized the Senate for failing to pass le
